Cargando…

Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis

Aplastic anaemia (AA) is a life‐threatening hematopoietic disorder characterized by hypoplasia and pancytopenia with increasing fat cells in the bone marrow (BM). The BM‐derived mesenchymal stem cells (MSCs) from AA are more susceptible to be induced into adipogenic differentiation compared with tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lu‐Lu, Liu, Lei, Liu, Hai‐Hui, Ren, Sai‐Sai, Dou, Cui‐Yun, Cheng, Pan‐Pan, Wang, Cui‐Ling, Wang, Li‐Na, Chen, Xiao‐Li, Zhang, Hao, Chen, Ming‐Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111807/
https://www.ncbi.nlm.nih.gov/pubmed/29993187
http://dx.doi.org/10.1111/jcmm.13761
_version_ 1783350735604285440
author Liu, Lu‐Lu
Liu, Lei
Liu, Hai‐Hui
Ren, Sai‐Sai
Dou, Cui‐Yun
Cheng, Pan‐Pan
Wang, Cui‐Ling
Wang, Li‐Na
Chen, Xiao‐Li
Zhang, Hao
Chen, Ming‐Tai
author_facet Liu, Lu‐Lu
Liu, Lei
Liu, Hai‐Hui
Ren, Sai‐Sai
Dou, Cui‐Yun
Cheng, Pan‐Pan
Wang, Cui‐Ling
Wang, Li‐Na
Chen, Xiao‐Li
Zhang, Hao
Chen, Ming‐Tai
author_sort Liu, Lu‐Lu
collection PubMed
description Aplastic anaemia (AA) is a life‐threatening hematopoietic disorder characterized by hypoplasia and pancytopenia with increasing fat cells in the bone marrow (BM). The BM‐derived mesenchymal stem cells (MSCs) from AA are more susceptible to be induced into adipogenic differentiation compared with that from control, which may be causatively associated with the fatty BM and defective hematopoiesis of AA. Here in this study, we first demonstrated that levamisole displayed a significant suppressive effect on the in vitro adipogenic differentiation of AA BM‐MSCs. Mechanistic investigation revealed that levamisole could increase the expression of ZFP36L1 which was subsequently demonstrated to function as a negative regulator of adipogenic differentiation of AA BM‐MSCs through lentivirus‐mediated ZFP36L1 knock‐down and overexpression assay. Peroxisome proliferator‐activated receptor gamma coactivator 1 beta (PPARGC1B) whose 3′‐untranslated region bears adenine‐uridine‐rich elements was verified as a direct downstream target of ZFP36L1, and knock‐down of PPARGC1B impaired the adipogenesis of AA BM‐MSCs. Collectively, our work demonstrated that ZFP36L1‐mediated post‐transcriptional control of PPARGC1B expression underlies the suppressive effect of levamisole on the adipogenic differentiation of AA BM‐MSCs, which not only provides novel therapeutic targets for alleviating the BM fatty phenomenon of AA patients, but also lays the theoretical and experimental foundation for the clinical application of levamisole in AA therapy.
format Online
Article
Text
id pubmed-6111807
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61118072018-09-01 Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis Liu, Lu‐Lu Liu, Lei Liu, Hai‐Hui Ren, Sai‐Sai Dou, Cui‐Yun Cheng, Pan‐Pan Wang, Cui‐Ling Wang, Li‐Na Chen, Xiao‐Li Zhang, Hao Chen, Ming‐Tai J Cell Mol Med Original Articles Aplastic anaemia (AA) is a life‐threatening hematopoietic disorder characterized by hypoplasia and pancytopenia with increasing fat cells in the bone marrow (BM). The BM‐derived mesenchymal stem cells (MSCs) from AA are more susceptible to be induced into adipogenic differentiation compared with that from control, which may be causatively associated with the fatty BM and defective hematopoiesis of AA. Here in this study, we first demonstrated that levamisole displayed a significant suppressive effect on the in vitro adipogenic differentiation of AA BM‐MSCs. Mechanistic investigation revealed that levamisole could increase the expression of ZFP36L1 which was subsequently demonstrated to function as a negative regulator of adipogenic differentiation of AA BM‐MSCs through lentivirus‐mediated ZFP36L1 knock‐down and overexpression assay. Peroxisome proliferator‐activated receptor gamma coactivator 1 beta (PPARGC1B) whose 3′‐untranslated region bears adenine‐uridine‐rich elements was verified as a direct downstream target of ZFP36L1, and knock‐down of PPARGC1B impaired the adipogenesis of AA BM‐MSCs. Collectively, our work demonstrated that ZFP36L1‐mediated post‐transcriptional control of PPARGC1B expression underlies the suppressive effect of levamisole on the adipogenic differentiation of AA BM‐MSCs, which not only provides novel therapeutic targets for alleviating the BM fatty phenomenon of AA patients, but also lays the theoretical and experimental foundation for the clinical application of levamisole in AA therapy. John Wiley and Sons Inc. 2018-07-11 2018-09 /pmc/articles/PMC6111807/ /pubmed/29993187 http://dx.doi.org/10.1111/jcmm.13761 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Liu, Lu‐Lu
Liu, Lei
Liu, Hai‐Hui
Ren, Sai‐Sai
Dou, Cui‐Yun
Cheng, Pan‐Pan
Wang, Cui‐Ling
Wang, Li‐Na
Chen, Xiao‐Li
Zhang, Hao
Chen, Ming‐Tai
Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis
title Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis
title_full Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis
title_fullStr Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis
title_full_unstemmed Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis
title_short Levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through ZFP36L1‐PPARGC1B axis
title_sort levamisole suppresses adipogenesis of aplastic anaemia‐derived bone marrow mesenchymal stem cells through zfp36l1‐ppargc1b axis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111807/
https://www.ncbi.nlm.nih.gov/pubmed/29993187
http://dx.doi.org/10.1111/jcmm.13761
work_keys_str_mv AT liululu levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT liulei levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT liuhaihui levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT rensaisai levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT doucuiyun levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT chengpanpan levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT wangcuiling levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT wanglina levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT chenxiaoli levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT zhanghao levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis
AT chenmingtai levamisolesuppressesadipogenesisofaplasticanaemiaderivedbonemarrowmesenchymalstemcellsthroughzfp36l1ppargc1baxis